ID
Bron
Aandoening
elderly with non-specific complaints
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
To assess the successful usage of the wearable biosensor with the smartphone app (i.e. patient feedback, caregiver feedback, raw device data, technical operational data),
Achtergrond van het onderzoek
This study is designed to investigate the efficacy of wearable monitoring devices for elderly NSC-patients in 2 different use case scenarios. Use case 1 (patients in the pre-hospital setting), Use case 2 (patients discharged home from the ED or hospital). Each patient will wear a biosensor (on the chest) connected to an app (a smartphone is running the app) for a certain period of time as defined by the clinical investigation plan – the biosensor will measure vital signs and biometric signals. At the end of the study period, the patients will be asked some questions related to usability of the wearable biosensor with the smartphone app.
Onderzoeksopzet
30 days
Onderzoeksproduct en/of interventie
The participants will wear a wearable biosensor that will record the vital parameters continuously
Publiek
Celine Reverseau
High Tech Campus 34
Eindhoven 5656 AE
The Netherlands
m:+31-6-31639778
celine.reverseau@philips.com
Wetenschappelijk
Celine Reverseau
High Tech Campus 34
Eindhoven 5656 AE
The Netherlands
m:+31-6-31639778
celine.reverseau@philips.com
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Group 1: Optimal triage in the pre-hospital setting
• Age ≥ 65 years;
• Patient at the GP’s office with non-specific complaint(s) only;
• Patient living in a home residence with/without home care or home residence;
• ISAR score ≥ 2;
• Informed consent.
Group 2: Follow-up of discharged patients from the internal medicine ward/ED.
• Age ≥ 65 years;
• Registered at the ED for Internal Medicine or patients will be discharged from the hospital;
• Patients do not present with specific complaints;
• Patients are ready for discharge home;
• Patients living at home (with/without home care) or home residence;
• ISAR ≥3;
• Informed consent.
Group 3: Control
• Age ≥ 65 years;
• Informed consent.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Group 1: Optimal triage in the pre-hospital setting
• Patients with positive anamnesis and/or medical examination for specific complaints;
• Age < 65 year;
• Patients with life expectancy <3 months (terminally ill patients);
• ISAR score <2.
• Patients who have implanted defibrillators or pacemakers
• Damaged or very vulnerable skin around patch location
• Allergic to silicone or hydrocolloid adhesive materials
Group 2: Follow-up of discharged patients from the internal medicine ward/ED.
• Age < 65 years;
• Other specialties besides internal medicine;
• Patients with diagnosed dementia;
• Patients living in a nursing home;
• Patients with an active oncologic disease;
• Patients with a live expectancy of less than 3 months;
• ISAR <3 score.
• Patients who have implanted defibrillators or pacemakers
• Damaged or very vulnerable skin around patch location
• Allergic to silicone or hydrocolloid adhesive materials
Group 3: Control
• Age < 65 year;
• Co-morbidities
• Patients with life expectancy <3 months (terminally ill patients);
• Patients who have implanted defibrillators or pacemakers
• Damaged or very vulnerable skin around patch location
• Allergic to silicone or hydrocolloid adhesive materials
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL5851 |
| NTR-old | NTR6031 |
| Ander register | : Philips Research |